Who is sponsoring NCT05159297?

NCT05159297 is sponsored by Asir John Samuel.

What drugs are being tested in NCT05159297?

Interventions in NCT05159297: Reference values.

What condition does NCT05159297 study?

NCT05159297 studies Coordination Disorder, Developmental.

Is NCT05159297 still recruiting?

NCT05159297 is currently completed. Last updated 5 October 2023.

Last reviewed 2023-10-05 · How we verify

NCT05159297

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Normative Reference Values of Equilibrium Coordination Test Among Children

Completed Last updated 5 October 2023

What this trial tests

trial testing Reference values in Coordination Disorder, Developmental in 1,104 participants. Completed in 16 September 2023.

Timeline

2 November 2021

Primary endpoint
19 August 2023

16 September 2023

Quick facts

Lead sponsor	Asir John Samuel
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,104
Start date	2 November 2021
Primary completion	19 August 2023
Estimated completion	16 September 2023
Sites	1 location across India

Drugs / interventions tested

Reference values

Conditions studied

Coordination Disorder, Developmental — all drugs for Coordination Disorder, Developmental →

Sponsor

Asir John Samuel

Who can join

Adults 8 to 17, any sex, with Coordination Disorder, Developmental. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A cross-sectional study will be conducted recruiting children of age group 8-15 years. Pilot study has been conducted for the determination of the sample size. The calculated sample size has come out to be, n=378 which can be taken for males and females separately. Stratified random sampling will be done according to age. Child will be asked to perform all tests one by one and the time taken (in seconds) will be noted required to perform the tests. The mean of three readings will be obtained using a mobile-based stop watch.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Asir John Samuel trials

Trials by the same sponsor.

NCT05160519 — Class IV Laser Therapy on Ejection Fraction, Cardio Biomarkers and Functional Outcomes · NA · unknown
NCT04084743 — Dual Task and Virtuality Training Innovation to Improve Balance, Posture and Gait in Patients With Parkinson Disease · NA · unknown
NCT05267223 — Experience of Rehabilitation Amongst Individuals With Paraplegia · unknown
NCT05077787 — Tactile and Kinaesthetic Stimulation in Neonates With Hyperbilirubinaemia · NA · completed
NCT04321655 — Reduce Pain and Improve Quality of Life in Patient With Knee Osteoarthritis by Light, Sound and Brain Stimulation · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05159297 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asir John Samuel
Last refreshed: 5 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05159297.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing